Antitubercular agent-36 , CAS No.2883173-82-6

CAS: 2883173-82-6 Cat. No.: A1416489 분자식: C18H17N3O3 분자량: 323.35
주문 가능
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
크기
USA
독일 (EU)*
가격
수량
1mg
A1416489-1mg
주문제작 · 8~12주
Enter a quantity for the sizes you want to add.

개요

Antitubercular agent-36 (compound 53) is an antitubercular agent. Antitubercular agent-36 inhibits the growth of Mtb H37Rv with a MIC 90 value of 1.25 μg/mL. Antitubercular agent-36 can be used for the research of tuberculosis.

사양

보관 조건
Store at -20°C
배송
Ice chest + Ice pads
이 제품은 콜드 체인 배송이 필요합니다.지상 및 기타 경제 서비스는 사용할 수 없습니다.
작업 유형
INHIBITOR
이름과 식별자
분자량
323.35

고급 데이터

인증서(CoA, COO, BSE/TSE 및 분석 차트)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
솔루션 계산기
리뷰

고객 리뷰

Application Protocols

No tested applications, protocols, or recommended conditions are provided in the Product Data for this SKU.

  • Only user-developed methods are applicable at this time. Please consult your institutional SOPs and validate conditions locally.
  • If protocol guidance becomes available (e.g., assay conditions, recommended concentrations, plate formats), it will be included in revised documentation.
Biological Roles

No specific biological target, pathway, or mechanism is provided for this item. The “Antitubercular agent” label indicates intended use in discovery research focused on Mycobacterium tuberculosis (Mtb) or related mycobacteria.

General context (literature; not specific to this item):

  • Mtb survival depends on pathways such as mycolic acid biosynthesis (e.g., InhA), arabinogalactan synthesis (e.g., DprE1), ATP synthase, DNA gyrase, and protein secretion/transport systems. Many modern screening campaigns probe these or unexplored targets.
  • Whole-cell antitubercular activity can arise from inhibition of cell wall assembly, energy metabolism, redox homeostasis, or transcriptional regulation.
  • Intrinsic barriers (lipid-rich cell envelope, efflux pumps) complicate uptake; physicochemical properties and efflux liability strongly influence apparent potency.

Practical implications for users:

  • When following up hits, confirm bacteriostatic vs bactericidal effects, assess inoculum effects, and profile spectrum across fast/slow-growing mycobacteria.
  • Conduct counter-screens for cytotoxicity and general antibacterial activity to evaluate selectivity.

Disclaimer:

  • No biological activity or mechanism is claimed or implied for this specific SKU. Any performance must be determined empirically by the end user.
Buffer Applications

This product is not a buffering reagent. Accordingly, it does not have a typical buffering pH range or standard buffer recipes.

For users running bioassays (general guidance):

  • Prepare compound stocks in an appropriate organic solvent (commonly DMSO), then dilute into your assay buffer/media with mixing to minimize precipitation.
  • Choose assay buffers/media validated for your organism/target system (e.g., microbiological media for mycobacteria or biochemical assay buffers for enzymes), and verify tolerance to the final solvent percentage.

Item-specific buffer properties: Not applicable; no buffer-related specifications are provided for this item.

Green Alternatives

Greener handling focuses on the choice of solvents used to dissolve, formulate, or process small molecules during screening and analytics. Because the compound’s structure is undisclosed, solvent recommendations are general.

Comparison of common vs greener options (general guidance):

  • DMSO (benchmark): Excellent solvency, widely accepted in assays; not “green” per se but relatively low volatility/toxicity compared with DMF/NMP. Hygroscopic; waste accumulation can be significant in HTS.
  • DMF/NMP: Powerful but reproductive-toxicity concerns; consider avoiding if alternatives work.
  • Greener/co-greener options:
    • Cyrene (dihydrolevoglucosenone): Bio-based dipolar aprotic; good for some heteroaromatics; assay compatibility must be validated.
    • Propylene carbonate: Low volatility; miscible with many organics; viscous—may affect dispensing.
    • PEG-400 or glycerol derivatives: Useful as co-solvents; high viscosity can complicate HTS.
    • 2-MeTHF, CPME: Greener ethers for synthetic steps; less relevant for aqueous bioassays but useful if doing solution-phase chemistry.

Balanced considerations:

  • Verify compound solubility and biological compatibility before replacing DMSO.
  • Recycle solvent containers and consolidate compatible organic waste streams to reduce environmental footprint.
  • Miniaturize assays and optimize dispensing to cut solvent consumption.
Pharmaceutical Uses

No pharmacopeial status, excipient role, or manufacturing use is provided for this item.

  • This material is supplied strictly for research use only and is not intended for human or animal therapeutic, diagnostic, or clinical applications.
  • Typical use case (general): as a research chemical in preclinical discovery for assay development, screening, and structure–activity relationship (SAR) exploration where permitted by institutional guidelines.

Item-specific regulatory/compendial information: Not specified for this item; refer to CoA/Spec Sheet if available under your agreement.

Physical Properties

The Product Data do not include physicochemical specifications for this item.

Item-specific values (specifications):

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point / Boiling point: Not specified for this item; refer to CoA/Spec Sheet.
  • Density / Refractive index: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Not specified for this item; refer to CoA/Spec Sheet.
  • LogP / pKa: Not specified for this item; refer to CoA/Spec Sheet.

General guidance for library-type small molecules (literature/experience-based; not specific to this item):

  • Many drug-like screening compounds display moderate lipophilicity (clogP ~1–4, literature) and dissolve readily in polar aprotic solvents such as DMSO or DMF; aqueous solubility varies widely and often benefits from co-solvents or surfactants.
  • Thermal events (mp) can range broadly depending on crystallinity and heteroatom content; do not use generic values as specifications.

Practical tips:

  • When properties are unknown, perform a small-scale solubility screen (DMSO → DMF → MeOH/EtOH → aqueous with 0.5–1% DMSO or 0.01–0.05% non-ionic surfactant) to identify suitable handling conditions for assays.
  • Record any observed hygroscopicity or polymorphism during initial handling for internal reproducibility.
Quality and Grades

Item-specific quality attributes are not included in the Product Data.

  • Grade/Purity (specification): Not specified for this item; refer to CoA/Spec Sheet.
  • Stabilizers/Antioxidants: Not specified for this item; refer to CoA/Spec Sheet.

Context for screening compounds (general information, not item-specific):

  • Library molecules used in discovery are commonly supplied with HPLC purity (e.g., ≥90–95% by area) and identity confirmation by MS and/or NMR. Some suppliers include water/residual solvent content by KF/GC and salt form annotation. These are typical industry practices and not specifications for this SKU.
  • When UV transparency matters (e.g., plate-based absorbance readouts), low-UV-absorbing impurities are preferable; HPLC chromatograms (200–400 nm) help assess suitability.

Recommendations:

  • Request and review the CoA/Spec Sheet for this lot to confirm purity method (HPLC vs. UPLC), detection wavelengths, identity data (MS/HRMS, NMR), and any counterion/salt form.
  • If your workflow requires specific attributes (e.g., salt-free free base, metal analysis, residual solvent limits), please contact us before ordering to align the supplied lot with your needs.
Reaction and Applications

This product is designated as a screening compound (“Antitubercular agent”), intended primarily for biological evaluation rather than as a preparative reagent.

Applicability to synthetic chemistry:

  • Without structure disclosure, there is no reliable basis to recommend specific reactions, catalysts, or transformations. It is not typically positioned as a building block.

Research applications (general, non-item-specific):

  • Phenotypic screens: Evaluation in whole-cell assays against Mycobacterium spp. to identify growth inhibition under defined conditions.
  • Biochemical assays: If a putative target is known internally, enzymatic inhibition measurements (e.g., IC50 determination) can be performed; target information is not provided for this item.
  • Mechanistic follow-up: Time-kill curves, resistance selection and sequencing, or target overexpression/knockdown studies to infer mode of action (performed at the user’s discretion).

Practical guidance:

  • Begin with small-scale solubility and stability checks in the intended assay media.
  • Control for solvent effects and autofluorescence/absorbance if using optical readouts.
  • Maintain rigorous plate mapping and barcode tracking for library compounds to ensure data integrity.
Reaction Conditions

No reaction or transformation conditions are provided for this item, and the compound is not offered as a reagent for named reactions.

Non-applicability:

  • Typical entries for catalysts, temperatures, equivalents, and solvent systems are not meaningful here without a known structure or intended transformation.

General laboratory notes (handling-focused, not reaction guidance):

  • Prepare small test solutions to assess stability in your chosen solvent at room temperature and refrigerated conditions. Monitor by LC/MS if available to detect degradation or adsorption losses.
  • Avoid prolonged exposure to moisture and light until stability is established; store working aliquots cold and protected from light as appropriate for many bioactive small molecules.
Safety and Handling

Safety data specific to this SKU are not provided in the Product Data and may be disclosed on the SDS.

Item-specific safety information:

  • GHS classification: Not specified for this item; refer to SDS.
  • Signal word / H-statements / Pictograms: Not specified for this item; refer to SDS.

Known storage and logistics:

  • Storage: Store at −20°C (Product Data).
  • Shipment: Shipped in ice chest with ice pads (Product Data).

General laboratory precautions for bioactive small molecules (guidance; defer to SDS for authority):

  • PPE: Lab coat, safety glasses, and appropriate chemical-resistant gloves; handle powders in a fume hood or ventilated enclosure to avoid dust/aerosol generation.
  • Hygiene: Avoid ingestion, inhalation, and skin contact. Wash thoroughly after handling. Prohibit food/drink in the work area.
  • Engineering controls: Use chemical fume hood or biosafety cabinet if transferring into biological media.
  • Incompatibilities (general): Until identity is known, segregate from strong oxidizers, strong acids/bases, and reducing agents. Avoid prolonged exposure to light/air/humidity that may cause degradation.
  • Peroxide concerns: Not applicable unless the structure contains peroxide-forming motifs (unknown here).
  • First aid (overview): In case of contact, rinse affected area with water for at least 15 minutes; seek medical attention if irritation persists. If inhaled, move to fresh air; if ingested, do not induce vomiting—consult medical services. Follow SDS directions when available.

Waste disposal:

  • Dispose according to institutional chemical waste procedures; treat as hazardous organic waste unless otherwise specified on the SDS.
Solvent Selection

Without a disclosed structure, solvent handling should begin with broadly compatible, assay-friendly solvents, then adapt empirically.

General selection strategy (guidance):

  • Primary stock solvent: DMSO is typically preferred for small-molecule libraries due to broad solubilizing power and assay compatibility at low final %.
  • Secondary options: DMF, NMP, ethanol, methanol, acetonitrile; test for solubility and assay interference before adoption.
  • Aqueous workup: Dilute DMSO stocks into buffer/media slowly with mixing to minimize precipitation; keep final DMSO ≤0.5–1% v/v where possible (assay-dependent).
  • Surfactants: For hydrophobic compounds, 0.01–0.05% non-ionic surfactant (e.g., Tween-80 or Pluronic-type) in assay buffer can mitigate precipitation (verify biological compatibility).

Small comparison (general):

  • DMSO: Highest solubilizing power; widely accepted in bioassays; hygroscopic.
  • DMF/NMP: Strong solvents; can affect cells/enzymes—use at very low final %.
  • Ethanol/MeOH: Volatile and easier to remove; lower solubility for many heteroaromatics; potential biological effects.
  • Acetonitrile: Moderate solubility; good for HPLC preparations; volatility aids drying.

Practical tips:

  • Filter or centrifuge stock solutions if particulates persist.
  • Document solvent choice, lot-specific solubility limits, and any precipitation upon dilution for reproducibility.
Storage and Reconstitution

Item-specific storage and logistics:

  • Storage condition: Store at −20°C (Product Data).
  • Shipping: Ice chest with ice pads (Product Data).

Item-specific reconstitution details:

  • Reconstitution/solubility: Not specified for this item; refer to CoA/Spec Sheet.

General best practices for small-molecule screening compounds (guidance; not specifications):

  • Reconstitute initially in high-strength solvent (commonly anhydrous DMSO) to prepare a concentrated master stock; verify clarity and absence of particulates.
  • Prepare single-use aliquots in inert, low-bind tubes or plates to minimize freeze–thaw cycles and adsorption losses.
  • Store aliquots at −20°C or below in sealed containers with desiccant; allow to equilibrate to room temperature before opening to avoid condensation.
  • Track cumulative freeze–thaw events and time at ambient temperature; discard aliquots that show precipitation, discoloration, or LC/MS-detected degradation.

Labeling and documentation:

  • Record solvent, concentration, lot number, preparation date, and operator initials on each aliquot per your QA practices.
Structure and Identity

Concise overview of identity information provided for this screening compound.

  • SKU: A1416489
  • Product Name: Antitubercular agent-36
  • CAS: 2883173-82-6
  • Category: Small molecules and compound libraries (研究/筛选用途)
  • Intended use: For research use only

Item-specific identifiers (not provided in Product Data):

  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.

Structural features:

  • The “Antitubercular agent-36” designation indicates a member of a curated screening set aimed at discovering inhibitors of Mycobacterium tuberculosis pathways. Without a disclosed structure, specific functional groups, ring systems, stereochemistry, or 2D depiction cannot be described for this catalog entry.

Notes for users:

  • If structural identifiers are required for registration, LIMS upload, or computational work, please request the item’s CoA/Spec Sheet or structure disclosure (if available under your agreement).
Synthetic Utility

This SKU is positioned as a screening compound rather than a synthetic building block. Without disclosure of structure or functional groups, no reliable reagent behavior can be assigned.

General considerations (not item-specific):

  • Many library compounds contain transformable motifs (e.g., aryl halides, nitriles, heteroaryl nitrogens) that enable follow-up analog synthesis for SAR. However, such features for this item are not disclosed.
  • If you intend to derivatize the compound, request structural information and purity/form (free base vs salt) to plan synthetic routes and protection strategies.

Bottom line:

  • Treat this product primarily as a bioassay screening entity. Use separate, fully characterized building blocks for synthetic campaigns unless structure disclosure is available and permits derivatization.
Target Specificity

Item-specific target data are not provided.

  • Target/Pathway: Not specified for this item; refer to CoA/Spec Sheet or internal documentation.
  • Species/strain applicability: Not specified for this item.

Note:

  • Any target specificity, if known, should be validated independently by the end user through biochemical or genetic assays. No specificity is claimed for this SKU.

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.